Patents by Inventor Mauro Piacentini

Mauro Piacentini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and Pharmaceutical Composition for Modulation Polarization and Activation of Macrophages
    Publication number: 20200297749
    Abstract: The present invention relates to methods and pharmaceutical composition for modulation polarization and activation of macrophages. In particular, the present invention relates to methods for modulating macrophage M1/M2 polarization in a subject in need thereof comprising administering to the subject a therapeutically effective amount of P2Y2 receptor agonists or antagonists.
    Type: Application
    Filed: March 31, 2020
    Publication date: September 24, 2020
    Inventors: Jean-Luc PERFETTINI, Audrey PAOLETTI, Marie-Lise GOUGEON, Guido KROEMER, Mauro PIACENTINI
  • Methods and Pharmaceutical Composition for Modulation Polarization and Activation of Macrophages
    Publication number: 20180125876
    Abstract: The present invention relates to methods and pharmaceutical composition for modulation polarization and activation of macrophages. In particular, the present invention relates to methods for modulating macrophage M1/M2 polarization in a subject in need thereof comprising administering to the subject a therapeutically effective amount of P2Y2 receptor agonists or antagonists.
    Type: Application
    Filed: May 20, 2016
    Publication date: May 10, 2018
    Inventors: Jean-Luc Perfettini, Audrey Paoletti, Marie-Lise Gougeon, Guido Kroemer, Mauro Piacentini
  • Methods and pharmaceutical compositions for treating human immunodeficiency virus type 1 (HIV-1) infections
    Patent number: 9938528
    Abstract: The present invention provides methods and pharmaceutical compositions for treating human immunodeficiency virus type 1 (HIV-1) infections. In particular, the present invention relates to a method for treating HIV-1 infection in a subject in need thereof comprising administering the subject with a therapeutically effective amount of an inhibitor of SGT1 activity or expression.
    Type: Grant
    Filed: December 10, 2015
    Date of Patent: April 10, 2018
    Assignees: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), UNIVERSITE PARIS-SUD, INSTITUT GUSTAVE ROUSSY, UNIVERSITE PARIS DECARTES, UNIVERSITE PIERRE ET MARIE CURIE, INSTITUT PASTEUR, INSTITUTO NAZIONALE PER LE MALATTIE INFETTIE IRCCS LAZZARO SPALLANZANI, ASSISTANCE PUBLIQUE HOPITAUX DE PARIS (APHP)
    Inventors: Guido Kroemer, Jean-Luc Perfettini, Marie-Lise Gougeon, Awatef Allouch, Mauro Piacentini
  • Methods and Pharmaceutical Compositions for Treating Human Immunodeficiency Virus Type 1 (HIV-1) Infections
    Publication number: 20170342411
    Abstract: The present invention provides methods and pharmaceutical compositions for treating human immunodeficiency virus type 1 (HIV-1) infections. In particular, the present invention relates to a method for treating HIV-1 infection in a subject in need thereof comprising administering the subject with a therapeutically effective amount of an inhibitor of SGT1 activity or expression.
    Type: Application
    Filed: December 10, 2015
    Publication date: November 30, 2017
    Inventors: Guido KROEMER, Jean-Luc PERFETTINI, Marie-Lise GOUGEON, Awatef ALLOUCH, Mauro PIACENTINI
  • Method for quantitatively measuring apoptosis
    Patent number: 5750360
    Abstract: The invention encompasses methods of detecting and/or quantifying .epsilon.(.gamma.-glutamyl)lysine isodipeptide by catalytically releasing lysine, then measuring free lysine.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: May 12, 1998
    Assignee: LXR Biotechnology Inc.
    Inventors: Laszlo Fesus, Mauro Piacentini